Legend Biotech Corporatio...

NASDAQ: LEGN · Real-Time Price · USD
37.27
-0.44 (-1.17%)
At close: Aug 15, 2025, 2:32 PM

Legend Biotech Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
627.24M 285.14M 117M 89.79M
Cost of Revenue
234.58M 144.21M 65.36M 313.35M
Gross Profit
392.66M 140.93M 51.64M -223.55M
Operating Income
-303.24M -439.49M -455.83M -393.02M
Interest Income
61.2M 54.49M 8.18M 971K
Pretax Income
-158.13M -520.12M -445.72M -386.21M
Net Income
-177.03M -518.25M -446.35M -386.21M
Selling & General & Admin
284.26M 200.93M 174.05M 149.48M
Research & Development
413.54M 382.22M 335.65M 313.35M
Other Expenses
-1.91M n/a 2.23M -6.07M
Operating Expenses
695.9M 140.93M 509.7M 462.83M
Interest Expense
21.61M 21.79M 10.8M 900K
Selling & Marketing Expenses
147.48M 94.16M 93.42M 102.54M
Cost & Expenses
930.48M 727.36M 575.06M 462.83M
Income Tax Expense
18.89M -1.86M 625K 1K
Shares Outstanding (Basic)
91.43M 88.04M 79.52M 70.43M
Shares Outstanding (Diluted)
91.43M 88.04M 79.52M 70.43M
EPS (Basic)
-1.94 -5.88 -5.62 -5.48
EPS (Diluted)
-1.94 -5.88 -5.62 -5.48
EBITDA
-113.16M -477.87M -416.54M -392.38M
EBIT
-136.52M -498.32M -434.93M -406.3M
Depreciation & Amortization
23.36M 20.45M 18.39M 13.92M